Navigation Links
GranuFlo Lawsuits News: Calif. Lawsuit Alleges Drug Maker Hid Serious Health Risks, Rottenstein Law Group LLP Reports
Date:8/30/2013

(PRWEB) August 30, 2013

A group of plaintiffs have filed a GranuFlo lawsuit in California state court, alleging that drug maker Fresenius sold dialysis drug GranuFlo while failing to inform the public of the serious potential risks of use of the drug, including heart attack and stroke, according to court documents. The Rottenstein Law Group LLP, which represents clients in GranuFlo dialysis injury lawsuits, maintains a web page that features information on GranuFlo side effects and lawsuits.

In June 2012 the U.S. Food and Drug Administration issued a Class 1 Recall after learning about the alleged adverse side effects involving the heart.* The FDA had originally approved the drug for distribution in 2003. The plaintiffs argue in the lawsuit that Fresenius warned its doctors at its own dialysis centers about the health risks of GranuFlo, but it did not warn anyone outside the organization (Rodriguez et al. v. Fresenius USA Inc. et al.; BC519374, Los Angeles Superior Court, California). According to court documents, the FDA received a copy of the memo in March 2012 and subsequently took action.

“If these very serious allegations are true, then the courts should hold this company accountable,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “The plaintiffs—and our own clients on whose behalf we file GranuFlo lawsuits—put their lives in the hands of this company and deserve justice.”

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of GranuFlo to download a free informational brochure about the drug to learn more about its side effects and how to file a lawsuit.

*fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm305630.htm

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

                            ###

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/heart-attack/prweb11076996.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
5. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
6. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
7. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
8. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
9. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
11. GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office accelerates and supports FNCC’s ... added 10 new sales professionals over the past 6 months and is continuing to ... hires over the course of 2017. , “This new office is a direct ...
(Date:3/27/2017)... ... March 27, 2017 , ... Mt. ... launch of a months-long rebranding effort. This includes the introduction of new packaging ... discussions and market research, we learned that a simple, proactive approach to wellness ...
(Date:3/27/2017)... Orange, Texas (PRWEB) , ... March 27, 2017 ... ... celebration at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to ... giveaways and will be an opportunity for area-residents to celebrate two great years ...
(Date:3/27/2017)... ... ... The homeowner improvement and repair market is expected to reach $317 billion ... renovations is also on the rise. Per a 2017 report, 13% of all households ... to use a licensed contractor.(2) The risks associated with improper renovations—especially tiling—can not only ...
(Date:3/26/2017)... ... 2017 , ... Local physician Dr. Justin Harper is one ... honoring the top influencers on RealSelf—the most trusted online destination to get informed ... , In 2016, more than 82 million people visited RealSelf to research cosmetic ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company ... in children, today reported financial results for the ... 2016 and provided an update on its corporate ... progress during the fourth quarter of 2016 through ... safety study, and with our lead development candidate, ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets ... Market, 2017-2027" report to their offering. ... The Cell Therapy Manufacturing ... growing market of cell therapy manufacturing and focuses both on ... These therapies are anticipated to emerge as viable alternatives to ...
(Date:3/24/2017)... March 24, 2017  Zymo Research Corp., ... Hamilton Robotics, Inc., who designs, manufactures and ... collaboration that teams Zymo Research,s DNA methylation ... DNA extraction products with Hamilton,s high-throughput automation ... methods for microbiomics and RNA isolation for ...
Breaking Medicine Technology: